Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $11.27 | Prev. Close $11.94 | Circuit Range N/A |
Day Range $11.27 - $11.54 | Year Range $0.91 - $16.34 | Volume 689 |
Average Traded $11.40 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $11.86 | $11.94 | +9.40% |
06-Apr-26 | $10.89 | $10.91 | +3.02% |
02-Apr-26 | $10.59 | $10.59 | +1.39% |
01-Apr-26 | $10.16 | $10.45 | +21.31% |
30-Mar-26 | $8.61 | $8.61 | +0.70% |
27-Mar-26 | $8.78 | $8.55 | +3.45% |
23-Mar-26 | $8.43 | $8.27 | -1.37% |